All right, good morning, everyone. My name is Margaret Brodie, and I'm the CEO of Rubicon Organics. You can hear me okay at the back? Great. We've seen what's happened in the cannabis markets the last few years, but I'm here to tell you why you should be paying attention again to Canadian cannabis and what's about to happen globally in terms of cannabis in the world. We now, today, have a global shortage of cannabis in legal markets. New countries are turning on, and there are very, very few companies that are able to produce premium quality. We're one of them. Rubicon Organics has a track record. We deliver on our promises, and we offer a compelling valuation. In particular, you look at our total assets versus our market cap and our profitability, it's there today. We have premium positioning in Canada, and we have a solid balance sheet with near-term growth opportunities, and we're looking to lean into those. We have an offering underway right now, and I will talk to that at the end of this presentation. Happy to take any questions. We see that the industry is very aware of momentum happening. The investor is not yet aware of that. What we're seeing is a lot of freneticism for supply in Canada and internationally, the U.S. market being on the beginning of a down, and I'll talk about that. There is excitement, and you can actually see value investors coming into our stock, and we've had a lot more volume this year than we had last year. I'm going to make you read our disclaimer because we do have an offering up, but I know you've all read it before, right, before this presentation. Great. Our vision is to become the most trusted house of cannabis brands in Canada and beyond through elevated experiences that are through quality and world-class genetics. We want to build brands that are on shelf for 30 years. Who are we? Rubicon Organics. I'm going to assume that most of you are new to the story. We are Canada's number one premium licensed producer, or LP, with a premium house of cannabis brands and over 6% of the Canadian cannabis premium market. We hold about 2% of national market share. We're based in Delta, British Columbia, and we're listed on the TSXV. We grow in living soil, which is unique, and it is a key competitive advantage to why our product is premium. We hold unique IP. Today, we are the world's leading scaled organic and certified organic cannabis company. Just recently, in December, we won and swept the Canadian Kind Awards, which are really the Oscars of Canadian cannabis. We won Brand of the Year, Vape of the Year, Topical of the Year, Hash of the Year, Flower of the Year. That is important because it's voted on by bud tenders. I couldn't go in and vote. It's really important when you're in a market where there's a recommend over the counter. We're in our third year. We just delivered our third year of profitability, and we have a proven brand platform from which to launch our brands. This year, we are 2024, we launched Vape. We got to 55% national distribution, and we won Vape of the Year and Best New Product of the Year with that product. We deliver consistent high quality. From day one, we've been committed to that. It's everything from production to cultivation to how we go out into market. We believe it's essential in competing, especially in a dark market. It's making us a leader in the industry. We also have a team that has deep cannabis experience, both legacy and CPG. We believe that we're positioned to achieve high valuation models à la tobacco and CPG as we go along, and the brands get stickier. Look, the last couple of years have been very quiet and down for Canadian cannabis. There's been nobody interested, and it's actually really nice to see a room this full. I think this year, this time next year, there's going to be more people in the room because this is just turning on. We believe that we've laid the foundations and we're ready for what's next. We are driving growth in Canada's premium sector, and we're positioned for growth, and we're going to talk about that today. We've got three years of profitability, as I mentioned. We've got a strong balance sheet. We've got leading brands. We've got world-class genetics, and we have a really strong independent board for governance who are extremely experienced and well-known in the Canadian space and engaged. They don't give me an easy time, which is probably a good thing. Quickly, I'm going to talk about our Q4 results. It was a record year, Q4. We delivered record net revenue. In the last quarter of the year, we were up 42% on the previous year. That was because of our vape launch largely and growth across all of our categories. We reported Adjusted EBITDA profitability of $4 million. There was around $1 million of one-time cost for an ERP, so we're sitting around $5 million. We swept the kind of awards, as I mentioned. Our wellness brand remains number one in the Canadian cannabis market. We've got around 27% of that market. We refinanced our credit facility, and we executed on our vape launch, and it was hugely successful. In 2025 this year already, we've received a significant international certification called GACP, and we've done our inaugural international shipment. I'll talk more about that in a minute. We've entered an agreement to purchase a new facility. We expect that to close in the second quarter. That will expand our annual production capacity by about 40% to over 15,000 kilos of premium supply. Very exciting. I'd like to get to the numbers right away. Here you go. You can get a snapshot of our financial picture. We just demonstrated consistent growth throughout 2024, and we had an improved mix and margin as we went through the year. Again, our Adjusted EBITDA here is including those one-time costs. In our Adjusted EBITDA, the only items that we take out are there's a cannabis revenue that goes in for it's called biological assets under IFRS. We strip that out. We take out our share-based compensation and our depreciation and amortization, and that's it. Our one-time costs that we incur are still in here. We saw growth across all of our categories, and our working capital position continues to be strong. At December 31, it was just under $20 million. We refinanced our credit facility at 6.75% interest rate for five years with fantastic lenders. We want to build this company where real operators want to build it for growth. What is next? How do we do it? This is what everybody asks. We have three flagship brands: Simply Bare Organics, which is catering to the connoisseur, cannabis connoisseur looking for new news. We have 1964 Supply Co., looking for the premium customer who is recruiting from the legacy market. We really want to bring those people in. Our Wildflower wellness brand, and I will speak to Homestead in a minute. In a market where the consumer can't see what's in the package and you buy something sight unseen, I mean, last time, when was the last time you opened up a beer and it wasn't good and it was off? That was the consistent experience that people had in Canadian cannabis for a long time. To build a brand promise, you have to be really fierce about that. Otherwise, you just have a label on a package. We believe that by delivering consistent, best-in-class quality, putting quality first, we deliver trust and a brand promise. I think we can all see in the world that we live today, consistency and trust is something that we're looking for. We built our reputation and the platform of our brands off of the power of our premium flower. We won flower of the year in both 2020 and 2024. Didn't get it in 2023, I have to say. I was very frustrated. That is a high bar, pun intended, in Canada, and we have a very strong and robust competitive market. To win in that market really means something. It goes to show how we can play as this world turns on. Our brand and launchpad, its launchpad has been a proven platform for what we can do. Bud tenders are surveyed by third parties the last two years. We were two of the top five brands, most recommended brands by bud tenders in a Brightfield survey. We launched edibles in 2023. What you're going to see in my track record as CEO is I'm going to tell you something, and then we're going to go out and deliver on it. In the fall of 2022, we hinted at looking at edibles. We then went out in the spring, announced we were going out with edibles, and managed to capture almost 30% of the premium edibles market. We are currently, or excuse me, in the fourth quarter of last year, we managed to be the number five premium edibles producer in the country. That is all outsourced product, and we have done that without using the power of our balance sheet and saving our balance sheet for the right opportunity. Same thing, we went out and did it again last year. We hinted in the fall of 2023 on vape. We then went out, announced that we were coming out with vape, and managed to launch two SKUs in May, June, July, really into our largest market in July. We achieved 55% national distribution in the first six months. I like to win. We like to do that. I like to build a competitive market. Very pleased to be 13% of the national resin vape market within six months. Pretty incredible. We also won Vape of the Year and Best New Product of the Year with our Blue Dream. Very exciting. It was our fastest, most successful launch ever. There is more to come in that category from us. I will talk about where that is a growth opportunity for us. It is successful because of the quality that we do in the beginning. Everything we do, we want to step forward with quality. Wildflower, same thing. We have really one dominant SKU. There's been a lot of competition enter in the last year, and we continue to win with that one strong SKU that people love and go back to. Homestead, why is this fourth one here on this list? It's because Homestead is where we put product quality that doesn't meet our first two premium quality stories. So if it can't meet Simply Bare or 1964, we can turn it into cash very quickly by putting it into the Homestead brand. We believe true CPG brands are going to be beginning to emerge, and we have a team that's experienced in that, and we're demonstrating that through our consistent brand promise, and I'm excited about that. Here's some results that we've got. We've had double-digit growth in British Columbia, Ontario, and Alberta. We have some work to do in Quebec, not being local there. That makes a difference. We have used, as I mentioned, our balance sheet to drive that growth. We have been able to capture meaningful market share and awards with the bud tender love. I would remind you that everything in Canada is purchased over the counter. You have to actually speak to someone to be able to purchase your product. The bud tender is absolutely critically important. Execution is a big part of this game, and you can see through our results that we are executors and business operators. What I care about as CEO is not just executing on a product that I can stand behind. I care about the second purchase on it. We sent something into market in July. Our vapes went into market in Ontario, and I was asked, how are you going to know that is successful? Boy, you sold in all this product. It's not successful until I see people rebuy it. Even more excitingly is when they recommend it to others. That's the flywheel that we're on right now. It's pretty exciting, actually. We're currently getting calls in from all over the world. Growth in just the Canadian market. Look, we think that the Canadian market is going to continue to grow. We're seeing new adopters come in every day. 30%-40% of consumers are still buying in the legacy market, and the new generation consumer has only ever bought in the legal market. We're also seeing significant international demand, and new markets are coming online, and there is a supply shortage. I don't think that that's been identified. I'll talk in a minute about why aren't you just turning on old facilities. Also, cannabis is accretive to Canada's GDP, not subject to tariffs at this time, and it's a medicine in many, many countries. It is pretty exciting. How do we grow our business from where we are today? Firstly, we always look to outpace industry growth, so that's just table stakes for us. We have a HOPE acquisition I'm going to speak about on the next slide. We expect to increase our supply capacity by over 40%. This, combined with long-term third-party supply agreements, is helping us meet growing demand. Our demand, we are supply constrained at this stage. Our edibles portfolio that we launched in 2023 grew 185% last year and continues to show strong growth. We're excited to have a full year of vape in market. We started out with two SKUs last summer. We got to five by the end of the year. This year we've got seven in market, so that will be a great growth lever for us. Quebec is announcing that vape is coming online. We do not yet know if we're successful with listings there, but optimistic. We see vape just growing overall. This whole pie is going to grow. In the U.S. market, it's sort of 26%-30% depending on the market. In Canada, it's only 16%-17% of the market. That shows you that there's a lot of room in there. It's all about leading with genetics. Very important to have new news, kind of like fashion, bringing out the next thing. As I mentioned, we have our new GACP certification, and we've sent our first shipment internationally. Our plan for 2025, given that we're capacity constrained, is a walk, crawl, win strategy. We're going to test and learn. I'm actually in Berlin next week, and we like to meet with people we do business with. We do business with people. We don't do business with brokers. We're looking to build out that strategy. We expect in 2026 we're going to have more supply, and some of that supply will be going into the international markets, which will be incremental EBITDA into our business. What's this? This is our, you can see on the left, the cool picture is our Delta facility. It's the existing largest scaled organic facility in the world at this stage. It's producing. We're very excited about it. It's how we've built our business.